Psychosis Biomarker Study

Purpose

This study is recruiting those ages 8–35 who have experienced psychosis. It is investigating biomarkers in psychosis, with particular interest in immunology markers, including neuronal antibodies.

  • Type of Study: Observational type
  • Setting of Study: Outpatient
  • Providing Clinical Treatment?: No
  • No-Cost Treatment?: No
  • Care Is Provided in Languages: English
 

Study Activities

  • Filling Out Forms
  • Blood Samples
  • Blood Samples for DNA
  • Provides Payment: Compensation for study-related procedures
 

Eligibility

  • Ages Eligible for Study: 8–35 Years
  • Genders Eligible for Study: Both
  • This study is also recruiting healthy volunteers.
 

Criteria

  • Inclusion Criteria: Those ages 8–35 who have experienced any type of psychosis in the past or currently, and who are willing to give blood and urine and undergo an approximately 2-hour evaluation.
  • Division: Child and Adolescent Psychiatry
  • Principal Investigator: Shannon Delaney, M.D.
  • Co-investigator: Brian Fallon, M.D.
 

Investigators

Principal Investigator: Shannon Delaney, M.D.

Co-investigator: Brian Fallon, M.D.

 

Contact Information

For more information, please contact:

Shannon Delaney
Phone: (347) 560-9006
Email: sld2158@cumc.columbia.edu